Samjin Pharmaceuticals Co., Ltd. (005500.KS) KSC

Currency In KRW

AD

Valuation

Market Cap241.98B
Enterprise Value365.79B
P/E Ratio10.28
PEG Ratio-0.23
Price/Sales Ratio0.75
Price/Book Ratio0.83
Enterprise/Revenue1.12
Enterprise/EBITDA16.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue309.13B
Revenue/Share24,201.99
Gross Profit153.03B
EBITDA44.5B
Net Income24.17B
Diluted EPS1,962.68

Balance Sheet

Total Cash8.11B
Total Cash/Share640.56
Total Debt119.98B
Total Debt/Equity0.43
Current Ratio1.28
Book Value Per Share22,011.03

Price History

52-Week Change-5.06
52-Week High25,900
52-Week Low16,990
Moving Average 50 Days19,448.2
Moving Average 200 Days19,441.4

Statistics

Average Volume216,834
Shares Outstanding12.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate800
Trailing Annual Dividend Yield4.4
Payout Ratio0.45
Last Split Factor1031:1000
Last Split DateDecember 29, 2010
AD